<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02502318</url>
  </required_header>
  <id_info>
    <org_study_id>BERNARD PRME 2014</org_study_id>
    <nct_id>NCT02502318</nct_id>
  </id_info>
  <brief_title>Medicoeconomic Evaluation of Two Surgical Techniques for Lobectomy in the Lung Cancer</brief_title>
  <acronym>LungSco01</acronym>
  <official_title>Medicoeconomic Analysis of Lobectomy Using Thoracoscopy vs Thoracotomy for Lung Cancer: a Multicentric Randomized Controlled Trial.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier Universitaire Dijon</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centre Hospitalier Universitaire Dijon</source>
  <brief_summary>
    <textblock>
      This is a national study that involves the participation of 600 lung cancer patients
      indicated that treatment is ablation of the pulmonary lobe. This technique is called
      lobectomy.

      Lobectomy may be performed in two different ways:

        -  Thoracotomy, which is the first reference approach and that is to make a large incision
           in the chest to pass between the ribs and spread the order to ablate the lobe.

        -  By video-thoracoscopy, which is a new surgical approach consisting in practice several
           small incisions in the chest wall to allow the introduction of a camera and special
           instruments to ablate the lobe.

      The mini-invasive nature of video-thoracoscopy has a positive impact on postoperative
      expectoration and ventilation. As a result, the incidence of postoperative respiratory
      complications including atelectasis, pneumonia and Acute Respiratory Distress Syndrome (ARDS)
      is reduced. These respiratory complications are responsible for prolonged stays in Intensive
      Care Unit (ICU) and overall hospitalisation. It also has an impact on recovery and quality of
      life when patients return home. The reduction in the incidence of complications should
      counterbalance the additional cost of video-thoracoscopy.

      This study aims to evaluate the effectiveness of these two techniques in relation to the
      quality of life and the costs they generate.

      Patients who agree to participate in the study were assigned to one or other of these groups
      (technical thoracotomy or video-thoracoscopy technique) by lot.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>July 2015</start_date>
  <primary_completion_date type="Anticipated">June 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The postoperative respiratory complications</measure>
    <time_frame>30 days after surgery</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>An incremental cost-utility ratio associated with the use of Video-Assisted Thoracic Surgery when compared with thoracotomy evaluated using the quality of life questionnary EQ-5D</measure>
    <time_frame>3 months after surgery</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">600</enrollment>
  <condition>Lung Cancer</condition>
  <condition>Lobectomy</condition>
  <arm_group>
    <arm_group_label>Lobectomy using video-thoracoscopy</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Lobectomy using thoracotomy</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Video-thoracoscopy</intervention_name>
    <arm_group_label>Lobectomy using video-thoracoscopy</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>thoracotomy</intervention_name>
    <arm_group_label>Lobectomy using thoracotomy</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients who have given their consent

          -  Any patient with proven or suspected lung cancer treated by lobectomy.

          -  Patients with a negative mediastinoscopy or negative &quot; EBUS-EUS &quot; following a PET scan
             showing uptake in mediastinal lymph nodes in the preoperative examination.

          -  Age between 18 and 80 years

          -  Patient affiliated to a social security regimen

          -  Patients with a WHO performance status equal to 0 or 1.

        Exclusion Criteria:

          -  Adults under wardship

          -  Pregnant or breast-feeding women

          -  Tumours in contact with the pulmonary artery or developing in the lobar bronchi after
             bronchial fibroscopy.

          -  Tumours in contact with the costal periosteum or invading the chest wall

          -  Tumours invading the mediastinal pleura or structures of the mediastinium (superior
             vena cava, trachea, the main-stem bronchi, aorta, oesophagus, vertebrae)

          -  Tumours invading the diaphragm

          -  Tumours invading the neurovascular structures of the apex (brachial plexus,
             subclavicular artery, subclavicular vein) causing Pancoast-Tobias syndrome

          -  Patients with histologically-proven contralateral or supraclavicular lymph node (N3)
             involvement whatever the harvesting method.

          -  Patients with a positive mediastinoscopy or positive &quot;EBUS-EUS&quot; following a &quot;PET scan&quot;
             with uptake in one or more mediastinal lymph nodes.

          -  Patients with metastasis (brain, bone, liver, adrenal glands, contralateral lung,
             pleura).

          -  Patients who have undergone neo-adjuvant chemotherapy and/or radiotherapy.

          -  Patients included in a neo-adjuvant chemotherapy and/or radiotherapy protocol.

          -  Patients who have already undergone thoracotomy.

          -  Patients with decompensated heart failure or with a systolic ejection fraction below
             30%.

          -  Patients with severe pulmonary artery hypertension.

          -  Patients with untreated valve disease.

          -  Patients with unstable angina despite appropriate treatment.

          -  Patients with untreated carotid stenosis greater than 70%.

          -  Patients with histologically proven cirrhosis with various decompensations or who have
             presented haemoptysis because of oesophageal varicose veins.

          -  Patients with severe neurological sequellae (hemiplegia, paraplegia, tetraplegia).

          -  Patients presenting severe psychiatric disorders (dementia, psychosis).
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Alain BERNARD</last_name>
    <phone>3.80.29.33.52</phone>
    <phone_ext>+33</phone_ext>
    <email>alain.bernard@chu-dijon.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Aline LAUBRIET-JAZAYERI</last_name>
    <phone>03-80-28-12-94</phone>
    <phone_ext>+33</phone_ext>
    <email>aline.laubriet@chu-dijon.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>CHU Amiens</name>
      <address>
        <city>Amiens</city>
        <zip>80000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Pascal BERNA</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Centre Jean Perrin - Clermont-Ferrand</name>
      <address>
        <city>Clermont-Ferrand</city>
        <zip>63000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marc FILAIRE</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>CHU Dijon</name>
      <address>
        <city>Dijon</city>
        <zip>21079</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alain BERNARD</last_name>
      <phone>380293352</phone>
      <phone_ext>+33</phone_ext>
      <email>alain.bernard@chu-dijon.fr</email>
    </contact>
    <contact_backup>
      <last_name>Aline LAUBRIET-JAZAYERI</last_name>
      <phone>03-80-28-12-94</phone>
      <phone_ext>+33</phone_ext>
      <email>aline.laubriet@chu-dijon.fr</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>HCL - Louis Pradel</name>
      <address>
        <city>Lyon</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jean-Michel MAURY</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>APHM Hôpital Nord</name>
      <address>
        <city>Marseille</city>
        <zip>13015</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Pascal-Alexandre THOMAS</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>CHU de Montpellier</name>
      <address>
        <city>Montpellier</city>
        <zip>34295</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Charles MARTY-ANE</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>CHU de Nice - Hôpital Pasteur</name>
      <address>
        <city>Nice</city>
        <zip>06000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Jérôme MOUROUX</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>APHP Hôpital Cochin</name>
      <address>
        <city>Paris</city>
        <zip>75014</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Pierre MAGDELEINAT</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>APHP Hôpital de Tenon</name>
      <address>
        <city>Paris</city>
        <zip>75020</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Jalal Assouad</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>CHU de Poitiers</name>
      <address>
        <city>Poitiers</city>
        <zip>86021</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Christophe JAYLE</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>CHU de Rennes - Hôpital de Pontchaillou</name>
      <address>
        <city>Rennes</city>
        <zip>35000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Bertrand DE LATOUR</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>CHU de Rouen</name>
      <address>
        <city>Rouen</city>
        <zip>76031</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Christophe PEILLON</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>HUS Strasbourg - Nouvel Hôpital Civil</name>
      <address>
        <city>Strasbourg</city>
        <zip>67000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Pierre-Emmanuel FALCOZ</last_name>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>April 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 15, 2015</study_first_submitted>
  <study_first_submitted_qc>July 17, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 20, 2015</study_first_posted>
  <last_update_submitted>April 5, 2017</last_update_submitted>
  <last_update_submitted_qc>April 5, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">April 6, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Proven or suspected lung cancer treated by lobectomy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lung Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

